ATTR Amyloidosis Treatment Market is driven by emerging gene therapies

a adăugat un sunet Health

2025-05-13 09:39:43 -

The ATTR Amyloidosis Treatment Market involves pharmaceutical and biotech products designed to treat transthyretin amyloidosis, a rare disorder caused by misfolded transthyretin proteins that deposit as amyloid fibrils in multiple organs. Key therapies include TTR stabilizers, gene-silencing oligonucleotides, and monoclonal antibodies, each offering distinct advantages like improved patient...

0 Commentarii 0 Distribuiri 578 Views 0 previzualizare